These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8430429

  • 1. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 2. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC, Wilson DW, Segall HJ.
    Toxicology; 1993 Mar 30; 79(1):21-35. PubMed ID: 8475497
    [Abstract] [Full Text] [Related]

  • 3. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE, Gunaga KP, Wagner JG, Hoorn CM, Moorehead WR, Roth RA.
    Toxicol Appl Pharmacol; 1994 Jun 30; 126(2):301-10. PubMed ID: 8209383
    [Abstract] [Full Text] [Related]

  • 4. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jul 30; 121(1):129-37. PubMed ID: 7687795
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms and pathology of monocrotaline pulmonary toxicity.
    Wilson DW, Segall HJ, Pan LC, Lamé MW, Estep JE, Morin D.
    Crit Rev Toxicol; 1992 Jul 30; 22(5-6):307-25. PubMed ID: 1489509
    [Abstract] [Full Text] [Related]

  • 6. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
    Taylor DW, Wilson DW, Lamé MW, Dunston SD, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1997 Mar 30; 143(1):196-204. PubMed ID: 9073608
    [Abstract] [Full Text] [Related]

  • 7. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
    Hoorn CM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jun 30; 120(2):281-7. PubMed ID: 8511798
    [Abstract] [Full Text] [Related]

  • 8. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC, Huxtable RJ.
    Toxicol Appl Pharmacol; 1995 Jan 30; 130(1):1-8. PubMed ID: 7839357
    [Abstract] [Full Text] [Related]

  • 9. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 30; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
    Broderick TL, King TM.
    Med Sci Monit; 2008 Dec 30; 14(12):BR261-4. PubMed ID: 19043358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 30; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 13. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec 30; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 14. Modulation of monocrotaline-induced cor pulmonale by grape juice.
    Ludke AR, Mosele F, Caron-Lienert R, Ribeiro MF, Partata W, Llesuy S, Araujo AS, Singal P, Belló-Klein A.
    J Cardiovasc Pharmacol; 2010 Jan 30; 55(1):89-95. PubMed ID: 19904214
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.
    J Androl; 2009 Jan 30; 30(5):495-504. PubMed ID: 19201699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats.
    Jin HF, Du SX, Zhao X, Wei HL, Wang YF, Liang YF, Tang CS, Du JB.
    Acta Pharmacol Sin; 2008 Oct 30; 29(10):1157-66. PubMed ID: 18817619
    [Abstract] [Full Text] [Related]

  • 19. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
    Hilliker KS, Garcia CM, Roth RA.
    Res Commun Chem Pathol Pharmacol; 1983 May 30; 40(2):179-97. PubMed ID: 6410470
    [Abstract] [Full Text] [Related]

  • 20. Effects of a chronic exercise training protocol on oxidative stress and right ventricular hypertrophy in monocrotaline-treated rats.
    Souza-Rabbo MP, Silva LF, Auzani JA, Picoral M, Khaper N, Belló-Klein A.
    Clin Exp Pharmacol Physiol; 2008 Aug 30; 35(8):944-8. PubMed ID: 18430062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.